Intensive systolic blood pressure control
1 paper1 finding
- 1 lab in 1 country
- Funders: Alzheimer’s Disease Research Center, University of Washington and others
- 1 of 1 finding with company ties
- Human trial1
Outcomes
1Cerebral small vessel disease
downin humans1
1 study
Cerebral small vessel disease
downin humans1
Intensive systolic blood pressure control decreases cerebral small vessel disease in humans (Cohen's d = -0.40 (95% CI, -0.62 to -0.17)).
Human trialhypertensive adults aged ≥50 years3.9 years
EClinicalMedicine11 Aug 2026
Latest
1 in 12 monthsEClinicalMedicine
Intensive versus standard blood pressure control and overall brain small vessel disease burden: a post-hoc analysis of the SPRINT randomized clinical trial
Randomised trial in 663 peopleInterventions